SCHWANNOMAS

Clinical trials for SCHWANNOMAS explained in plain language.

Never miss a new study

Get alerted when new SCHWANNOMAS trials appear

Sign up with your email to follow new studies for SCHWANNOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Hope for schwannomatosis pain: new drug trial launches

Symptom relief Recruiting now

This study tests two experimental drugs, siltuximab and erenumab, to see if they can safely reduce chronic pain in people with schwannomatosis, a condition that causes painful nerve tumors. About 40 adults with moderate-to-severe pain will receive either a drug or a placebo. The …

Matched conditions: SCHWANNOMAS

Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief

Last updated Jun 27, 2026 12:23 UTC

SCHWANNOMAS

Get alerted when new SCHWANNOMAS trials appear

Hope for schwannomatosis pain: new drug trial launches